N-(2-(2-Hydroxy-4-(methylsulfonamido)-5-phenoxyphenyl)-2-oxoethyl)formamide, 97%, 250mg

Methyl trans-2-Octenoate>95.0%(GC)25mL

9,9'-(6-Chloro-1,3,5-triazine-2,4-diyl)bis(9H-carbazole), 97%, 100g

(4-(N,N-Diethylsulfamoyl)-2-methylphenyl)boronic acid, 95.0%, 100mg

ethyl 8-[4-(morpholinomethyl)phenyl]-8-oxooctanoate, 97.0%, 1g

Bicyclo[4.2.0]octa-1,3,5-trien-3-amine, 95.0%, 250mg

Dialysis membrane Spectra/Por® Biotech CE MWCO 20,000, 10 mm, 1 Piece(s)

1-[2-Amino-1-(3,4-dimethoxy-phenyl)-ethyl]-pyrrolidine-3-carboxylic acid hydrochloride, 97.0%, 250mg

2-[3-(trifluoromethyl)phenyl]propanoic acid, 97%, 1g

N-Methyl-L-norleucine, 95%, 250mg

(2R)-2-Amino-2-phenylacetamide, 97.0%, 25g

1,3-dimethyl-2,4-dioxo-7-propyl-2,3,4,7-tetrahydro-1H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid, 95.0%, 250mg

{8-methyl-1,4-dioxaspiro[4.5]decan-8-yl}methanol, 98%, 250mg